Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report
Montesi S, Gomez C, Beers M, Brown R, Chattopadhyay I, Flaherty K, Garcia C, Gomperts B, Hariri L, Hogaboam C, Jenkins R, Kaminski N, Kim G, Königshoff M, Kolb M, Kotton D, Kropski J, Lasky J, Magin C, Maher T, McCormick M, Moore B, Nickerson-Nutter C, Oldham J, Podolanczuk A, Raghu G, Rosas I, Rowe S, Schmidt W, Schwartz D, Shore J, Spino C, Craig J, Martinez F. Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report. American Journal Of Respiratory And Critical Care Medicine 2024, 209: 362-373. PMID: 38113442, PMCID: PMC10878386, DOI: 10.1164/rccm.202307-1154ws.Peer-Reviewed Original ResearchConceptsSlow lung function declinePulmonary fibrosisLung function declineField of pulmonary fibrosisRisk factorsStudy pulmonary fibrosisProgressive pulmonary fibrosisIdiopathic pulmonary fibrosisPulmonary Fibrosis FoundationIdentification of risk factorsFunctional declineElucidation of disease mechanismsClinical trial designDisease risk factorsFibrosisImprove diagnosisTrial designBiomarker discoveryDisease mechanismsPulmonaryMedicationMorbidityTherapy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply